首页> 外文OA文献 >Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

【2h】

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

机译：接受阿哌沙班或华法林的房颤患者的大出血ARISTOTLE试验（阿哌沙班用于减少卒中和其他血栓栓塞性心律事件）：预测因素，特征和临床结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hylek Elaine M.; Held Claes; Alexander John H.; Lopes Renato D.; De Caterina Raffaele; Wojdyla Daniel M.; Huber Kurt; Jansky Petr; Steg Philippe Gabriel; Hanna Michael; Thomas Laine; Wallentin Lars; Granger Christopher B.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE trial (Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation): Predictors, characteristics, and clinical outcomes [J] . HylekE.M., HeldC., AlexanderJ.H., Journal of the American College of Cardiology . 2014,第20期

机译：接受阿哌沙班或华法林治疗的房颤患者的大出血：ARISTOTLE试验（阿哌沙班用于减少房颤中风和其他血栓栓塞事件）：预测因素，特征和临床结果
2. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial [J] . Garcia David A., Fisher Deborah A., Mulder Hillary, Autonomic neuroscience: basic & clinical . 2019,第1期

机译：用Apixaban或Warfarin治疗心房颤动患者的胃肠道出血：来自细胞腺癌的脑卒中和地心房颤动（亚里士多德）试验中的其他血栓栓塞事件的见解
3. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: A subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial [J] . GotoS., ZhuJ., LiuL., The American heart journal . 2014,第3期

机译：阿哌沙班与华法林相比在东亚心房颤动患者中预防卒中的疗效和安全性：阿哌沙班在减少房颤和其他血栓栓塞事件中的亚分析（ARISTOTLE）
4. Analysis of multiscale entropy characteristics of heart rate variability in patients with permanent atrial fibrillation for predicting ischemic stroke risk [C] . Ryo Matsuoka, Kohzoh Yoshino, Eiichi Watanabe, IEEE International Conference on Bioinformatics and Biomedicine . 2018

机译：永久性心房纤颤患者心率变异性的多尺度熵特征分析以预测缺血性中风风险
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Correction: Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [O] . 2021

机译：矫正：心房颤动患者血压控制和中风或全身栓塞的风险：中风血管和室心房颤动（亚里士多德）试验中的中风和其他血栓栓塞事件的结果
7. BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL [O] . Sandhu Roopinder K., Ezekowitz Justin, Andersson Ulrika, 2015

机译：甲状旁腺房颤患者（阿司匹沙定用于减少卒中和其他血栓性新陈代谢事件的试验）的身体质量指标和结果

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

著录项

相似文献

相关主题

期刊订阅